From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting

by Steven P. Rowe, Brandon Luber, Monique Makell, Patricia Brothers, JoAnn Santmyer, Megan D. Schollenberger, Hannah Quinn, Daniel L. Edelstein, Frederick S. Jones, Karen B. Bleich, William H. Sharfman, Evan J. Lipson
Published 2018-10-01